Anaemia after gastric sleeve surgery is a recognised long-term complication that can develop months or even years following the procedure. Sleeve gastrectomy removes approximately 75–80% of the stomach, reducing production of gastric acid and intrinsic factor — both essential for absorbing iron and vitamin B12. Combined with smaller meal portions and reduced dietary intake, this creates a cumulative risk of nutritional deficiency. Understanding why anaemia occurs, how to recognise it, and what monitoring and treatment are available on the NHS is essential for anyone who has undergone, or is considering, this procedure.

Why Anaemia Develops After Gastric Sleeve Surgery

Sleeve gastrectomy reduces gastric acid and intrinsic factor production, impairing iron and vitamin B12 absorption; smaller portions further reduce dietary micronutrient intake, creating a cumulative anaemia risk over time.

Sleeve gastrectomy is one of the most commonly performed bariatric procedures in the UK, involving the surgical removal of approximately 75–80% of the stomach to create a narrow, tube-shaped pouch. It is a primarily restrictive procedure — unlike gastric bypass, it does not reroute the small intestine, so the duodenum and jejunum remain in the digestive pathway. Whilst it is highly effective for weight loss and the management of obesity-related conditions, the procedure alters gastric physiology in ways that can predispose patients to nutritional anaemia over time.

The stomach's key contribution to micronutrient status is secretory rather than absorptive. It produces hydrochloric acid, which converts dietary iron from its ferric (Fe³⁺) form to the more readily absorbed ferrous (Fe²⁺) form, and intrinsic factor, a glycoprotein secreted by parietal cells that is essential for vitamin B12 absorption in the terminal ileum. When a large portion of the stomach is removed, both acid and intrinsic factor production are reduced. It is worth noting that the risk of B12 deficiency is generally lower after sleeve gastrectomy than after gastric bypass, because the absorptive small intestine is preserved; nonetheless, reduced intrinsic factor output remains a clinically relevant concern over time.

Beyond these physiological changes, patients eat considerably smaller portions after surgery, reducing overall dietary intake of iron, B12, folate, and other nutrients needed for red blood cell production. Additional modifiable factors — including long-term use of proton pump inhibitors (PPIs), which further suppress gastric acid, and untreated Helicobacter pylori infection — can compound the risk of deficiency and should be considered during assessment.

Together, these mechanisms create a cumulative risk of anaemia that can emerge months or even years after the initial procedure, making long-term monitoring — as outlined in the British Obesity and Metabolic Surgery Society (BOMSS) postoperative biochemical monitoring guideline — an essential component of post-operative care.

Common Nutritional Deficiencies Linked to Sleeve Gastrectomy

Iron deficiency is the most prevalent cause of post-sleeve anaemia; vitamin B12, folate, and less commonly copper deficiency also contribute, each requiring different treatment approaches.

Anaemia following gastric sleeve surgery is rarely caused by a single deficiency. Instead, it typically reflects a combination of micronutrient shortfalls, each contributing to impaired red blood cell production or function.

Iron deficiency is the most prevalent cause of post-operative anaemia in sleeve gastrectomy patients. Reduced gastric acid secretion impairs non-haem iron absorption, and many patients — particularly premenopausal women — have pre-existing iron stores that are already marginal before surgery. The risk of iron deficiency anaemia after sleeve gastrectomy is generally lower than after gastric bypass (which bypasses the duodenum, the primary site of iron absorption), but remains clinically significant. When interpreting ferritin results, it is important to note that ferritin is an acute-phase reactant; a concurrent C-reactive protein (CRP) should be measured to avoid overestimating iron stores in the presence of inflammation. A transferrin saturation below 20% provides additional supportive evidence of iron deficiency.

Vitamin B12 deficiency is also recognised after sleeve gastrectomy, given the reduction in intrinsic factor production. B12 deficiency may take longer to manifest clinically, as the body maintains hepatic stores for several years. Once depleted, it leads to megaloblastic anaemia, characterised by abnormally large, dysfunctional red blood cells, and can also cause neurological damage.

Folate (vitamin B9) deficiency can contribute to megaloblastic anaemia, particularly in patients with poor dietary variety or inconsistent supplementation. Deficiencies in copper and vitamin A are uncommon after sleeve gastrectomy but should be considered in patients with unexplained anaemia, neutropenia, or neurological features that do not respond to standard treatment.

Key deficiencies to be aware of include:

• Iron (ferritin with concurrent CRP; serum iron; transferrin saturation)

• Vitamin B12 (cobalamin)

• Folate

• Copper (if unexplained anaemia, neutropenia, or neuropathy)

• Vitamin D (indirectly affects haematopoiesis)

Understanding which deficiency is driving anaemia is critical, as treatments differ significantly. Giving iron alone in a patient with unrecognised B12 deficiency, for example, can mask neurological deterioration that may become irreversible if not treated promptly.

Recognising the Symptoms of Post-Operative Anaemia

Symptoms include persistent fatigue, pallor, breathlessness, and palpitations; B12 deficiency additionally causes peripheral neuropathy and balance problems, which can become irreversible without prompt treatment.

Anaemia after gastric sleeve surgery can develop gradually, meaning symptoms may be subtle at first and easily attributed to the normal recovery process or the demands of significant weight loss. Patients and clinicians alike should remain vigilant for signs that may indicate declining haemoglobin levels or specific micronutrient deficiencies.

General symptoms of anaemia include:

• Persistent fatigue and low energy, disproportionate to activity levels

• Pallor of the skin, gums, or inner eyelids

• Shortness of breath on exertion

• Heart palpitations or a sensation of a racing heartbeat

• Dizziness or light-headedness, particularly on standing

• Difficulty concentrating or 'brain fog'

In cases of iron deficiency anaemia specifically, patients may also notice brittle nails, hair thinning, a sore or smooth tongue (glossitis), or an unusual craving for non-food substances such as ice or clay — a phenomenon known as pica.

Vitamin B12 deficiency can produce additional neurological symptoms not seen with iron deficiency alone. These include tingling or numbness in the hands and feet (peripheral neuropathy), difficulty with balance, and mood changes including low mood or irritability. These neurological features can be irreversible if left untreated, and any patient experiencing them should seek urgent review from their GP or bariatric team without delay.

Red-flag symptoms requiring same-day assessment or emergency care (call 999 or go to A&E) include:

• Chest pain or severe breathlessness at rest

• Collapse or loss of consciousness

• Signs of significant bleeding, such as black or tarry stools (melaena), vomiting blood (haematemesis), or very heavy menstrual bleeding

For symptoms that are new, worsening, or causing concern but are not immediately life-threatening, patients should contact NHS 111 for advice or speak to their GP promptly. Symptoms should never be dismissed as simply 'part of the weight loss journey', and patients who have missed follow-up appointments or have not been taking prescribed supplements consistently should seek review as soon as possible.

Diagnosis and Monitoring: What to Expect on the NHS

BOMSS guidelines recommend blood tests at 3, 6, and 12 months post-operatively, then annually; the panel includes FBC, ferritin with CRP, B12, folate, and iron studies to detect deficiencies early.

In the UK, patients who have undergone bariatric surgery — including sleeve gastrectomy — should be enrolled in a structured follow-up programme. The BOMSS postoperative biochemical monitoring and supplementation guideline and the NHS England Bariatric Surgery (Adults) Service Specification set out the framework for lifelong nutritional monitoring, with blood tests conducted at regular intervals to detect deficiencies before they become clinically significant.

Typical monitoring schedules include blood tests at 3, 6, and 12 months post-operatively, and then annually thereafter. These tests are usually arranged through the bariatric multidisciplinary team (MDT) or, in some cases, delegated to the patient's GP under a shared care arrangement. The standard panel should include:

• Full blood count (FBC) — to assess haemoglobin, mean corpuscular volume (MCV), and red cell indices

• Serum ferritin and iron studies (including transferrin saturation) — ferritin is the most sensitive marker of iron stores, but should be interpreted alongside CRP to account for its behaviour as an acute-phase reactant

• Serum vitamin B12 and folate

• Vitamin D (25-OH) and calcium

• Parathyroid hormone (PTH) and bone profile

• Liver function tests

• Urea and electrolytes (U&E)

• Zinc and copper — if hair loss, peripheral neuropathy, neutropenia, or refractory anaemia is present

Thyroid function tests are not part of routine bariatric monitoring but should be requested if clinically indicated (for example, if symptoms of hypothyroidism are present, as this can also contribute to anaemia).

A low MCV (microcytic anaemia) typically suggests iron deficiency, whilst a raised MCV (macrocytic anaemia) points towards B12 or folate deficiency. Mixed deficiencies can produce a normal MCV, which may mask the underlying problem — reinforcing the importance of measuring individual micronutrients rather than relying on FBC alone. A ferritin below 30 micrograms/L is generally consistent with iron deficiency, though sensitivity is reduced in the presence of inflammation.

If anaemia is identified, further investigations may include reticulocyte count, serum methylmalonic acid (a sensitive marker of functional B12 deficiency), or anti-intrinsic factor antibodies. In patients with unexplained iron deficiency anaemia that does not respond to treatment, coeliac disease screening (tissue transglutaminase IgA antibody with total IgA) should be considered, and further gastrointestinal evaluation may be appropriate in line with BSG guidance.

Patients should be encouraged to attend all scheduled follow-up appointments and to raise any new symptoms with their care team between reviews.

Treatment Options for Anaemia Following Gastric Sleeve

Treatment depends on the deficiency: oral ferrous salts for iron deficiency, intramuscular hydroxocobalamin for B12 malabsorption, and folic acid 5 mg daily for folate deficiency, always after confirming the specific cause.

Treatment of post-operative anaemia is guided by the underlying cause, and a thorough diagnostic workup is essential before initiating therapy. Empirical treatment without identifying the specific deficiency is generally discouraged, as it may delay appropriate management.

Iron deficiency anaemia is typically treated with oral iron supplementation. In line with current NICE CKS and BSG guidance, one tablet of a ferrous salt daily (for example, ferrous sulphate 200 mg, providing approximately 65 mg elemental iron) is the recommended starting point, with alternate-day dosing considered in patients who experience significant gastrointestinal side effects — evidence suggests this may improve absorption and tolerability. Ferrous fumarate or ferrous gluconate are alternatives if ferrous sulphate is not tolerated. Common side effects include nausea, constipation, and dark stools.

Experiencing these side effects? Our pharmacists can help you navigate them →

To optimise absorption, oral iron should be taken with water or a small amount of vitamin C (for example, a glass of orange juice), and separated from tea, coffee, calcium-containing foods or supplements, and levothyroxine by at least two hours. The timing of PPI doses should also be considered, as acid suppression reduces iron absorption.

In patients who cannot tolerate oral preparations, or where absorption is significantly impaired, intravenous (IV) iron may be prescribed. Several IV iron preparations are available in the UK (including ferric carboxymaltose and ferric derisomaltose); the choice and dose should be guided by the prescribing clinician in accordance with the relevant Summary of Product Characteristics (SmPC). IV iron carries a risk of hypersensitivity reactions and should only be administered in a setting equipped to manage anaphylaxis. Ferric carboxymaltose in particular has been associated with hypophosphataemia, which may be symptomatic in some patients; serum phosphate should be monitored as clinically indicated. Patients who experience suspected side effects from any medicine, including IV iron preparations, should report these via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app).

Expected response to iron therapy includes a rise in reticulocyte count within approximately one week and an increase in haemoglobin of around 10 g/L every two to three weeks. A repeat blood count should be arranged within two to four weeks to confirm response, with ongoing monitoring thereafter.

Vitamin B12 deficiency is treated with intramuscular (IM) hydroxocobalamin in patients with significant malabsorption, as this bypasses the gastrointestinal tract entirely. UK regimens per the BNF are:

• Without neurological involvement: 1 mg IM three times per week for two weeks, then 1 mg every two to three months for maintenance

• With neurological involvement: 1 mg IM on alternate days until no further improvement, then 1 mg every two months

Neurological symptoms should be treated urgently, as delay risks irreversible damage. High-dose oral cyanocobalamin or hydroxocobalamin (1,000 micrograms daily) may be appropriate for patients with milder deficiency and confirmed adequate compliance, but IM administration is preferred where malabsorption is a concern.

Folate deficiency is treated with folic acid 5 mg daily for at least four months. It is essential to exclude or treat B12 deficiency concurrently, as folic acid supplementation alone can correct the haematological picture whilst allowing neurological damage from B12 deficiency to progress undetected.

All treatments should be reviewed and adjusted based on repeat blood tests, and patients should be supported by a dietitian experienced in bariatric nutrition to optimise dietary intake alongside supplementation.

Long-Term Prevention and Nutritional Support After Surgery

Lifelong use of a specialist bariatric multivitamin, regular blood monitoring, and dietitian support are the most effective strategies for preventing anaemia after gastric sleeve surgery.

Prevention is far preferable to treatment when it comes to anaemia after gastric sleeve surgery. The most effective strategy is consistent, lifelong adherence to a tailored supplementation regimen, combined with regular dietary review and blood monitoring in line with BOMSS guidance.

Most UK bariatric centres recommend that sleeve gastrectomy patients take a comprehensive bariatric multivitamin daily, which typically contains higher doses of iron, B12, folate, vitamin D, and other micronutrients than standard over-the-counter preparations. Standard multivitamins are generally insufficient for post-bariatric patients and should not be used as a substitute. Supplementation should be individualised based on blood results and reviewed regularly with the bariatric team or a specialist dietitian. Typical starting points, in line with BOMSS recommendations, include:

• Iron: additional elemental iron as guided by ferritin and transferrin saturation results; higher doses are often required for premenopausal women

• Vitamin B12: 1,000 micrograms orally daily, or 1 mg IM every three months, depending on local policy and individual absorption

• Folic acid: 400–800 micrograms daily as part of a bariatric multivitamin (higher doses — 5 mg daily — for women of childbearing age or those planning pregnancy)

• Vitamin D: maintenance dosing of 800–2,000 IU daily once replete, with higher replacement doses guided by serum 25-OH vitamin D levels and SACN/NICE recommendations

• Calcium: as indicated by bone profile and PTH results

Dietary advice should focus on maximising nutrient-dense food choices within the constraints of a reduced stomach capacity. Patients should be encouraged to prioritise lean protein sources, fortified foods, and a wide variety of vegetables and legumes. Red meat, shellfish, and dark leafy greens are valuable sources of iron and folate. Vitamin B12 is found only in animal products (meat, fish, dairy, and eggs) and in foods specifically fortified with B12 (such as certain plant-based milks and breakfast cereals); dark leafy greens do not provide B12 and should not be relied upon for this purpose.

Access to a specialist bariatric dietitian is a key component of long-term care and should be available through the NHS bariatric service or via GP referral. Patients who are pregnant or planning pregnancy require particular attention: folic acid 5 mg daily should be taken from at least one month before conception until 12 weeks of pregnancy, and early review by both the obstetric and dietetic teams is strongly recommended, as nutritional demands increase substantially during pregnancy and anaemia poses risks to both mother and baby.

Ultimately, anaemia after gastric sleeve surgery is largely preventable with the right support, education, and commitment to lifelong nutritional care. Patients are encouraged to view supplementation and monitoring not as optional extras, but as an integral part of their surgical outcome.

Frequently Asked Questions